| Financial Year |
March 31 2023 |
| Monetary Funds |
2,504,846.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
20,433,464.39 |
| Advances to Suppliers |
8,348,534.24 |
| Other Receivables |
147,452,767.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,120,248.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,707,291.96 |
| Total Current Assets |
203,567,152.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
60,373,680.14 |
| Investment Properties |
-- |
| Fixed Assetes |
112,887,303.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,090,301.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,513,388.86 |
| Deferred Income Tax Assets |
597,010.41 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,250,790,510.44 |
| Total Assets |
1,454,357,663.42 |
| Short-Term Loans |
363,083,480.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,302,698.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,973,252.95 |
| Taxes Payable |
1,923,871.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,102,270,169.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
369,061,172.30 |
| Other Current Liabilities |
638,269.34 |
| Sub-Total of Current Liabilities |
1,871,445,533.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,867,561.20 |
| Total Liabilities |
1,889,313,094.24 |
| Paid-In Capital(Or Share Stock) |
481,056,870.00 |
| Capital Surplus |
1,348,540,585.60 |
| Surplus Reserve |
33,481,335.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-984,087,815.91 |
| Minority Stockholder's Interest |
148,266.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-435,103,697.46 |
| Owner's Equity（Stockholder's Equity） |
-434,955,430.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,454,357,663.42 |
